Search

M2 PRESSWIRE-January 21, 2025-: Biotech Flavors Research Report 2024-2030 Featuring Bell Flavors & Fragrances, Firmenich, Givaudan, IFF, Kerry, Robertet, Sensient Technologies, Symrise, T. Hasegawa, and Takasago (C)1994-2025 M2 COMMUNICATIONS RDATE:21012025 [...]

M2 PRESSWIRE-September 30, 2024-: Bullous Keratopathy Market on Track for Major Expansion by 2034, According to DelveInsight | Aurion Biotechnologies, Emmecell, Cellusion, Trefoil Therapeutics,Price Vision Group (C)1994-2024 M2 COMMUNICATIONS RDATE:30092024 [...]

M2 PRESSWIRE-May 30, 2024-: Global Organic Soy Protein Isolates Market Analysis and Forecasts, 2024-2034 Featuring Prominent Players - The Scoular Co, ADM, Foodchem International, Chaitanya Agro Biotech, and Burcon (C)1994-2024 [...]

M2 PRESSWIRE-May 30, 2024-: Asia-Pacific Genomic Cancer Panel and Profiling Market Research 2023-2024 & 2033 Featuring Burning Rock DX and Genecast Biotechnology (C)1994-2024 M2 COMMUNICATIONS RDATE:30052024 The 'Asia-Pacific Genomic Cancer [...]

M2 PRESSWIRE-May 14, 2024-: High-grade Glioma Market 2032: Epidemiology Trends, Innovative Therapies, Regulatory Approvals by DelveInsight | Everfront Biotech Co., Ltd., BioMimetix JV, LLC, Chimerix, Laminar Pharma (C)1994-2024 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-May 10, 2024-: Dementia Market 2032: Epidemiology Data, Pipeline Breakthroughs, Regulatory Landmarks by DelveInsight | Charsire Biotech, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP (C)1994-2024 M2 COMMUNICATIONS RDATE:10052024 The Dementia [...]

M2 PRESSWIRE-May 10, 2024-: Chronic Wounds Market 2032: Epidemiology Review, Pipeline Breakthroughs, Regulatory Highlights by DelveInsight | Paracrine, Inc, Oneness Biotech, MediWound, Abeona Therapeutics, Inc, CereMark Pharma (C)1994-2024 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-May 10, 2024-: Severe Asthma Market Forecast by 2032: Epidemiology Analysis, Emerging Therapies, Regulatory Updates by DelveInsight | Sanofi, GlaxoSmithKline, EMS, Oneness Biotech, Incyte Crp, CSPC ZhongQi Pharma (C)1994-2024 [...]

M2 PRESSWIRE-April 18, 2024-: Pertussis Market Analysis 2032: Epidemiology, FDA Approvals, Clinical Trials, Therapies, Companies by DelveInsight | Sanofi Pasteur, Mitsubishi Tanabe Pharma, GlaxoSmithKline, ILiAD Biotechnologies (C)1994-2024 M2 COMMUNICATIONS RDATE:18042024 [...]

(GlobeNewswire) - The 'Collaboration Deals in Biotechnology 2019-2024' report has been added to ResearchAndMarkets.com's offering. The biotechnology sector continues to advance with groundbreaking research and development activities, fostering collaboration between [...]

DUBLIN -- The 'Cell Based Assay & High Content Screening Markets. Forecasts by User and Product. With Executive and Consultant Guides. 2024 to 2028' report has been added to ResearchAndMarkets.com's [...]

M2 PRESSWIRE-February 27, 2024-: World Cell Based Assay & High Content Screening Markets 2024-2028 with Executive and Consultant Guides - Immuno-oncology, Biotechnology and Pharmaceutical Research Play Leading Roles (C)1994-2024 M2 [...]

M2 PRESSWIRE-November 27, 2023-: Projected Surge in Chronic Traumatic Encephalopathy Market by 2032, Forecasts by DelveInsight | Companies: Prothena, Tetra Therapeutics, Brighton Biotech, Avid Radiopharma (C)1994-2023 M2 COMMUNICATIONS RDATE:24112023 (Albany, [...]

(GLOBE NEWSWIRE via COMTEX) -- Goal is to report UP421 proof of concept data in 2023 and 2024 Potential to remove immunosuppression from islet cell transplantation SEATTLE, Nov. 17, 2023 [...]

M2 PRESSWIRE-November 8, 2023-: Glabellar Lines Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Revance Therapeutics, ATGC Biotech, AbbVie, Ipsen, Eirion (C)1994-2023 [...]

DUBLIN -- The 'AI in Pathology Market by Component (Software, Scanners), Neural Network (CNN, GAN, RNN), Application (Drug Discovery, Diagnosis, Prognosis, Workflow, Education), End User (Pharma, Biotech, Hospital Labs, Research), [...]

M2 PRESSWIRE-November 3, 2023-: AI in Pathology Market Research Report 2023-2028: Focus on Drug Discovery, Diagnosis, Prognosis, Workflow, Education, Pharma, Biotech, Hospital Labs, &m Research (C)1994-2023 M2 COMMUNICATIONS RDATE:03112023 The [...]

DUBLIN -- The 'Enzyme Replacement Therapy Global Market Report 2023' report has been added to ResearchAndMarkets.com's offering. The global enzyme replacement therapy market is expected to grow from $10.03 billion [...]

M2 PRESSWIRE-October 2, 2023-: Chronic Norovirus Enteritis Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - Prosit Sole Biotechnology (C)1994-2023 M2 COMMUNICATIONS RDATE:29092023 [...]

M2 PRESSWIRE-September 28, 2023-: Global Enzyme Replacement Therapy (ERT) Market Research Report 2023-2032 Featuring Key Players - Biomarin Pharmaceutical, Leadiant Biosciences, Pfizer, Sanofi, & AbbVie (C)1994-2023 M2 COMMUNICATIONS RDATE:28092023 The [...]

DUBLIN -- The 'Global Market for White Biotechnology 2024-2034' report has been added to ResearchAndMarkets.com's offering. Key Highlights: * Comprehensive analysis of white biotechnology and its vast potential to produce [...]

M2 PRESSWIRE-September 11, 2023-: Adrenoleukodystrophy Clinical Trials, and Key Companies|Companies - Bluebird Bio, Minoryx Therapeutics, MedDay Pharmaceuticals, Magenta Therapeutics, Orpheris Inc, SOM Biotech, and many others (C)1994-2023 M2 COMMUNICATIONS RDATE:11092023 [...]

M2 PRESSWIRE-September 7, 2023-: Diabetic Foot Ulcer Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - Amniox/Tissue Tech, Biotherapy Services, Oneness Biotech (C)1994-2023 [...]

M2 PRESSWIRE-September 6, 2023-: Graft-versus-host disease (GVHD) Market: Analysis of Epidemiology, Pipeline Products, & Key Companies Working in the Market | Companies - CSL Behring, Medac, ElsaLys Biotech, Kadmon Therapeutics [...]

M2 PRESSWIRE-September 6, 2023-: Lamellar Ichthyosis Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - Galderma, Mayne Pharma, Krystal Biotech, Timber Pharmaceuticals (C)1994-2023 [...]

M2 PRESSWIRE-July 21, 2023-: Wet AMD Market expected to rise | Companies - Regeneron Pharmaceuticals, Novartis, Pfizer, Roche, Chengdu Kanghong Biotech, Kodiak Sciences, Opthea Limited, Alkahest Inc, Graybug Vision, REGENXBIO [...]

DUBLIN -- The 'Conjugation and Labeling Services Market: Focus on Protein Labeling, Peptide Labeling, Small Molecule Conjugation and Antibody Conjugation: Industry Trends and Global Forecasts, 2023-2035' report has been added [...]

M2 PRESSWIRE-June 26, 2023-: Pressure Ulcer Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working | Companies - Xantho Biotechnology, ReGeneRx Pharmaceuticals. Nuo Therapeutics (C)1994-2023 M2 COMMUNICATIONS RDATE:26062023 DelveInsight's [...]

M2 PRESSWIRE-June 22, 2023-: Multiple Sclerosis Pipeline, Clinical Trials, and NDA Approvals (2023) | Companies - TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, and others (C)1994-2023 M2 [...]

M2 PRESSWIRE-June 22, 2023-: Ischemic Stroke Pipeline, Clinical Trials, and NDA Approvals (2023) | Companies - Genentech, Supergene, Tasly Pharmaceutical, Pharmazz, GNT Pharma, NoNO, Angde Biotech Pharmaceutical, and others (C)1994-2023 [...]

M2 PRESSWIRE-June 21, 2023-: Minimal Residual Disease Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies |Companies - Adaptive Biotechnologies, Foresight Diagnostics, Cergentis B.V. ICON plc (C)1994-2023 M2 COMMUNICATIONS RDATE:21062023 [...]

M2 PRESSWIRE-June 21, 2023-: Mycosis Fungoides Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies|Companies - Yaupon Therapeutics, Moleculin Biotech Inc, Merck, Sorrento Therapeutics (C)1994-2023 M2 COMMUNICATIONS RDATE:21062023 DelveInsight's 'Mycosis [...]

M2 PRESSWIRE-June 20, 2023-: Age-related macular degeneration Market was approximately USD 9,840 million in 2021 by DelveInsight | Regeneron, Roche, Kodiak Sciences, REGENXBIO, Alkahest, Graybug Vision, Ribomic, Unity Biotech (C)1994-2023 [...]

M2 PRESSWIRE-June 20, 2023-: Metastatic Cutaneous Squamous Cell Cancer Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies | Companies - Henlius Biotech, Merck, Aulous Bioscience, Codiac Bioscience (C)1994-2023 M2 [...]

M2 PRESSWIRE-June 19, 2023-: Peripheral Arterial Disease Market expected to rise | Companies - NovoNordisk, Takeda, Mercator MedSystems, Beijing Northland Biotech, Ixaka Ltd, Humacyte, CardioVascular BioTherapeutics (C)1994-2023 M2 COMMUNICATIONS RDATE:19062023 [...]

M2 PRESSWIRE-June 16, 2023-: Netherton Syndrome Pipeline, NDA Approvals, Emerging Drugs and Clinical Trials (2023) | Companies - Novartis, Timber Pharma, Bridge Biopharma, Evotec AG, Dermelix Biotherapeutics, Krystal Biotech. (C)1994-2023 [...]

M2 PRESSWIRE-June 15, 2023-: Oncolytic Adenovirus Market expected to rise | Companies - Oncolytics Biotech, Amgen, Sorrento Therapeutics, Transgene SA, Daiichi Sankyo Company, Shanghai Sunway Biotech, Takara Bio (C)1994-2023 M2 [...]

M2 PRESSWIRE-June 14, 2023-: ATTR Amyloidosis Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | SOM Biotech, Neurimmune, Ionis, Alnylam, Intellia Therapeutics, Prothena (C)1994-2023 M2 [...]

M2 PRESSWIRE-June 8, 2023-: Oropharyngeal Cancer Market expected to rise | Companies - AstraZeneca, ISA Pharmaceuticals, Pfizer, Bristol Myers Squibb, Advaxis, PDS Biotechnology, Debiopharm, expected to boost the market (C)1994-2023 [...]

M2 PRESSWIRE-June 6, 2023-: Ovarian Clear Cell Carcinoma Market expected to rise, Genentech, GlaxoSmithKline, AstraZeneca, Clinigen Group, Novartis, Clovis Oncology, Ortho Biotech, Bristol-Myers Squibb, expected to drive market (C)1994-2023 M2 [...]

M2 PRESSWIRE-June 5, 2023-: DelveInsight Unveils Comprehensive Pipeline Insight for Metastatic Melanoma Treatment | Companies - Evaxion Biotech, InxMed, AiVita Biomedical, Iovance Biotherapeutics, Viralytics, Merck and Others (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-June 1, 2023-: Alopecia Areata Pipeline | Companies - Concert Pharmaceuticals, Equillium, Maxinovel Pharmaceuticals, TechnoDerma Medicines, Sichuan Kelun-Biotech Biopharmaceutical, Pfizer, Reistone Biopharma (C)1994-2023 M2 COMMUNICATIONS RDATE:01062023 DelveInsight's, 'Alopecia Areata [...]

M2 PRESSWIRE-May 31, 2023-: Cutaneous T-cell Lymphoma Market expected to rise, Soligenix, Moleculin Biotech, Innate Pharma, Bioniz, Codiak BioSciences, expected to drive market (C)1994-2023 M2 COMMUNICATIONS RDATE:31052023 DelveInsight's 'Cutaneous T-cell [...]

M2 PRESSWIRE-May 31, 2023-: Cutaneous Squamous Cell Carcinoma Market expected to rise, Incyte Corporation, Shanghai Henlius Biotech, Novartis, Rakuten Medical, Morphogenesis, Genentech, Berg Pharma, I-MAB Biopharma, Roche (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-May 31, 2023-: Cystic Fibrosis Market expected to rise, Algi Pharma, Verona Pharma, Translate Bio, Calithera Biosciences, Krystal Biotech, SpliSense, expected to drive market (C)1994-2023 M2 COMMUNICATIONS RDATE:31052023 DelveInsight's [...]

M2 PRESSWIRE-May 30, 2023-: Recurrent or Metastatic Head and Neck cancer Market expected to rise, Eisai Co Ltd., Sinocelltech, Merck, Nanobiotix, Sichuan Baili Pharmaceutical, Adlai Nortye Biopharma, BioNTech, PDS Biotechnology [...]

M2 PRESSWIRE-May 30, 2023-: Ankylosing Spondylitis (Bekhterev's Disease) Pipeline Insight | Companies - Fresenius Kabi, Shanghai Henlius Biotech, Pfizer, Fujifilm Kyowa Kirin Biologics, Hetero Biopharma, and Others (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-May 29, 2023-: Refractory Metastatic Melanoma Market expected to rise, Idera Pharmaceuticals, Bristol-Myers Squibb, Sunesin Pharmaceuticals, Taiga biotechnologies, BioNtech, expected to drive market (C)1994-2023 M2 COMMUNICATIONS RDATE:29052023 DelveInsight's 'Refractory [...]

M2 PRESSWIRE-May 29, 2023-: Ankylosing Spondylitis (Bekhterev's Disease) Pipeline Insight | Companies - Fresenius Kabi, Shanghai Henlius Biotech, Pfizer, Fujifilm Kyowa Kirin Biologics, Hetero Biopharma, Bio-Thera Solutions (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-May 29, 2023-: Chronic Back Pain Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Mesoblast, Vertanical, Persica, Synerkine, CHA Biotech, Eli Lilly, BDH [...]